Bioactive Compounds
-
A3346 Dabigatran ethyl esterSummary: Thrombin activity inhibitor -
A3378 E-3810Summary: VEGF/FGF dual inhibitor, potent and selective -
A3484 IguratimodSummary: COX-2 inhibitor,inhibits IL-1,IL-6,IL-8 and tumour necrosis factor. -
A3504 IRAK inhibitor 6Target: IRAKSummary: IRAK-4 inhibitor -
A3514 JAK2 Inhibitor V, Z3Summary: Jak2 tyrosine kinase inhibitor -
A3518 JDTic 2HClSummary: κ-opioid receptor antagonist -
A3519 JNK-IN-7Target: JNKSummary: Selective JNK inhibitor -
A3530 KN-92 hydrochlorideTarget: Ca2 /calmodulin-dependent protein kinases (CaMKs)Summary: Inactive derivative of KN-93,control compound -
A3535 KX2-391 dihydrochlorideTarget: SrcSummary: Src kinase, tubulin polymerization, HBV transcription, and botulinum neurotoxin A (BoNT/A) inhibitor -
A3536 L-165041Target: PPARSummary: PPARβ/δ agonist,cell permeable,potent and selective

